deltatrials
Unknown PHASE2 INTERVENTIONAL 2-arm NCT01784549

Customized Neoadjuvant Versus Standard Chemotherapy in NSCL Patients With Resectable Stage IIIA (N2)Disease (CONTEST)

A Multi-center Phase II Randomized Study of Customized Neoadjuvant Therapy Versus Standard Chemotherapy in Non-small Cell Lung Cancer (NSLC) Patients With Resectable Stage IIIA (N2) Disease (CONTEST-TRIAL)

Sponsor: ASL TO4, Chivasso

Updated 8 times since 2017 Last updated: Nov 23, 2014 Started: Jul 31, 2012 Primary completion: Oct 31, 2015 Completion: Dec 31, 2015
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01784549, this PHASE2 trial focuses on Non Small Cell Lung Cancer and remains ongoing. Sponsored by ASL TO4, Chivasso, it has been updated 8 times since 2012, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotUnknown Status~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshotUnknown Status~Jul 2018 – ~Jan 2019 · 6 months · monthly snapshotUnknown Status~Jan 2019 – ~Jan 2021 · 24 months · monthly snapshotUnknown Status~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – ~Mar 2026 · 18 months · monthly snapshotUnknown~Mar 2026 – present · 5 months · monthly snapshotUnknown

Change History

8 versions recorded
  1. Mar 2026 — Present [monthly]

    Unknown PHASE2

  2. Sep 2024 — Mar 2026 [monthly]

    Unknown PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE2

    Status: Unknown StatusUnknown

  4. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE2

  5. Jan 2019 — Jan 2021 [monthly]

    Unknown Status PHASE2

Show 3 earlier versions
  1. Jul 2018 — Jan 2019 [monthly]

    Unknown Status PHASE2

  2. Jun 2018 — Jul 2018 [monthly]

    Unknown Status PHASE2

  3. Jan 2017 — Jun 2018 [monthly]

    Unknown Status PHASE2

    First recorded

Jul 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • ASL TO4, Chivasso
  • Azienda Ospedaliera S. Maria della Misericordia
  • Azienda Ospedaliera San Camillo Forlanini
  • Azienda Ospedaliera San Gerardo di Monza
  • Azienda Ospedaliera San Giovanni Battista
  • Azienda Ospedaliera Sant'Andrea
  • Azienda Ospedaliera Santa Maria Degli Angeli
  • Azienda Ospedaliera Spedali Riuniti di Livorno, Livorno
  • Azienda Ospedaliera Universitaria Integrata Verona
  • Azienda Ospedaliera dei Colli Monaldi-Cotugno-CTO, Napoli
  • Azienda Ospedaliera, Ospedale Civile di Legnano
  • Azienda Sanitaria Locale di Cagliari
  • Azienda Sanitaria Locale n.2 Savonese
  • Azienda Sanitaria Universitaria Integrata del Trentino
  • IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy
  • Istituto Clinico Humanitas
  • Istituto Tumori Giovanni Paolo II, BARI
  • Ospedale Santa Croce-Carle Cuneo
Data source: IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations